TY - JOUR
T1 - Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition
AU - Tai, Ningwen
AU - Ding, Yuyan
AU - Schmitz, John C.
AU - Chu, Edward
N1 - Funding Information:
This work was supported by grants from the National Cancer Institute (CA16359 and CA82897 to E.C.). The authors also wish to thank the Yale Cancer Center and the VA CT Cancer Center, VA CT Healthcare System for their continued support of this research.
PY - 2002/10/15
Y1 - 2002/10/15
N2 - Previous studies have shown that human dihydrofloate reductase (DHFR) acts as an RNA-binding protein, in which it binds to its own mRNA and, in so doing, results in translational repression. In this study, we used RNA gel mobility shift and nitrocellulose filter-binding assays to further investigate the specificity of the interaction between human DHFR protein and human DHFR mRNA. Site-directed mutagenesis was used to identify the critical amino acid residues on DHFR protein required for RNA recognition. Human His-Tag DHFR protein specifically binds to human DHFR mRNA, while unrelated proteins including thymidylate synthase, p53 and glutathione-S-transferase were unable to form a ribonucleoprotein complex with DHFR mRNA. The Cys6 residue is essential for RNA recognition, as mutation at this amino acid with either an alanine (C6A) or serine (C6S) residue almost completely abrogated RNA-binding activity. Neither one of the cysteine mutant proteins was able to repress the in vitro translation of human DHFR mRNA. Mutations at amino acids Ile7, Arg28 and Phe34, significantly reduced RNA-binding activity. An RNA footprinting analysis identified three different RNA sequences, bound to DHFR protein, ranging in size from 16 to 45 nt, while a UV cross-linking analysis isolated an ∼16 nt RNA sequence bound to DHFR. These studies begin to identify the critical amino acid residues on human DHFR that mediate RNA binding either through forming direct contact points with RNA or through maintaining the protein in an optimal structure that allows for the critical RNA-binding domain to be accessible.
AB - Previous studies have shown that human dihydrofloate reductase (DHFR) acts as an RNA-binding protein, in which it binds to its own mRNA and, in so doing, results in translational repression. In this study, we used RNA gel mobility shift and nitrocellulose filter-binding assays to further investigate the specificity of the interaction between human DHFR protein and human DHFR mRNA. Site-directed mutagenesis was used to identify the critical amino acid residues on DHFR protein required for RNA recognition. Human His-Tag DHFR protein specifically binds to human DHFR mRNA, while unrelated proteins including thymidylate synthase, p53 and glutathione-S-transferase were unable to form a ribonucleoprotein complex with DHFR mRNA. The Cys6 residue is essential for RNA recognition, as mutation at this amino acid with either an alanine (C6A) or serine (C6S) residue almost completely abrogated RNA-binding activity. Neither one of the cysteine mutant proteins was able to repress the in vitro translation of human DHFR mRNA. Mutations at amino acids Ile7, Arg28 and Phe34, significantly reduced RNA-binding activity. An RNA footprinting analysis identified three different RNA sequences, bound to DHFR protein, ranging in size from 16 to 45 nt, while a UV cross-linking analysis isolated an ∼16 nt RNA sequence bound to DHFR. These studies begin to identify the critical amino acid residues on human DHFR that mediate RNA binding either through forming direct contact points with RNA or through maintaining the protein in an optimal structure that allows for the critical RNA-binding domain to be accessible.
UR - http://www.scopus.com/inward/record.url?scp=0037109121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037109121&partnerID=8YFLogxK
U2 - 10.1093/nar/gkf562
DO - 10.1093/nar/gkf562
M3 - Article
C2 - 12384595
AN - SCOPUS:0037109121
SN - 0305-1048
VL - 30
SP - 4481
EP - 4488
JO - Nucleic acids research
JF - Nucleic acids research
IS - 20
ER -